South Korea

Sample report by Neurophet Aqua
By  Adam Ang 02:54 am April 13, 2023
South Korean health tech company Neurophet has obtained certification from Singapore's Health Sciences Authority for its AI-enabled degenerative brain disease diagnosis assistant software.  Its flagship software, Neurophet Aqua, analyses brain MRI using AI to check for brain atrophy and white matter degeneration as seen in neurodegenerative diseases such as Alzheimer's disease and vascular...
Interface of Coreline Soft's AVIEW Neuro CAD
By  Adam Ang 06:12 am March 31, 2023
South Korea clears Coreline Soft's AI brain haemorrhage detection software An AI-powered brain haemorrhage detection software by medtech company Coreline Soft is now listed as a non-insured medical device in South Korea following its approval from the Ministry of Food and Drug Safety.  The software product called AVIEW Neuro CAD automatically detects cerebral haemorrhages in brain CT scans and...
Sky Labs' CART-I Plus ring as worn on a finger
By  Adam Ang 01:39 am March 30, 2023
South Korean health tech startup Sky Labs has recently obtained the approval of the South Korean Ministry of Food and Drug Safety for the latest blood pressure monitoring feature on its ring-type health monitoring device.  Worn on the finger, CART-I Plus uses PPG and sensor algorithms to measure and monitor blood pressure continuously around the clock. It provides a range of blood pressure data,...
A sample scan analysis of Lunit INSIGHT DBT
By  Adam Ang 12:06 am March 24, 2023
Lunit obtains new CE mark for AI DBT solution South Korean medical AI company Lunit has received a CE mark under Europe's latest Medical Device Regulation for its AI software for digital breast tomosynthesis (DBT) analysis. Called Lunit INSIGHT DBT, the software solution analyses 3D images from DBT, enabling fast and accurate diagnosis of breast cancer.  In a press statement, Lunit disclosed its...
A researcher using a digital tablet in a laboratory.
By  Adam Ang 02:56 am March 21, 2023
A research team from the Korea Advanced Institute of Science and Technology has developed an AI model to predict adverse reactions between oral anti-COVID-19 medication and prescription drugs. Researchers from KAIST's Department of Biochemical Engineering made a new version of the DeepDDI AI-based drug interaction prediction model to check how ritonavir and nirmatrelvir, two components of...
New MetaNose breath analyser by Metanoia Sensing
By  Adam Ang 02:23 am March 10, 2023
Singaporean startup develops breath test for analysing fat burning Metanoia Sensing, a deep tech startup in Singapore, has come up with a breath analyser to help people monitor their fat burning and gain insights into their metabolic health risks. The non-invasive device called MetaNose uses a Micro-Electro-Mechanical System acetone sensor and a proprietary signal processing algorithm to measure...
Coreline Soft's flagship product, AVIEW LCS, an AI-powered automatic pulmonary nodule analysis solution
By  Adam Ang 10:34 pm March 8, 2023
South Korean medtech firm Coreline Soft has obtained the United States Food and Drug Administration's 510(k) clearance for its latest AI-powered analysis software for screening lung nodules. The company develops AI imaging solutions for diagnosing various chest conditions, aortic disease, spinal disease, and metastatic cancer in the chest.  WHAT IT DOES Its latest software-as-a-medical device...
A person checking their vitals on a smartwatch
By  Adam Ang 11:11 pm February 16, 2023
South Korea clears first local insomnia DTx  The South Korean Ministry of Food and Drug Safety has given its first market approval for a digital therapeutic device for treating insomnia, according to a news report. The mobile-based medical device-as-a-software called Somzz by Aimmed delivers a CBT programme that helps increase sleep duration. India OKs health monitoring smartwatch CardiacSense...
Asa Ren DNA test
By  Adam Ang 11:14 pm February 9, 2023
Indonesian DNA data firm Asa Ren scores $8M funding Asa Ren, one of the first DNA data companies in Indonesia, has raised $8.15 million in a funding round joined by Kejora Capital and Silicon Valley-based investors Top Harvest Capital and Marcy Venture Partners. Northstar Ventures, Naya Capital, PT Diagnos Laboratorium Utama Tbk and other angel investors also participated in the round. The...
A pathologist handling blood samples in a Guardant Health lab
By  Adam Ang 11:24 pm January 31, 2023
South Korean AI company Lunit has tied up with its investor, Guardant Health, for AI integration. Under the partnership, Lunit will integrate its PD-L1 scoring algorithm into Guardant's cancer biomarker detection workflow in the Guardant360 TissueNextTM PD-L1 test for non-small cell lung cancer (NSCLC). Lunit SCOPE PD-L1, a CE-marked AI solution, detects and analyses PD-L1, a type of cancer...